BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 9244390)

  • 1. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
    Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
    Walter M; Plotnick M; Schechter NM
    Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
    Schechter NM; Brass LF; Lavker RM; Jensen PJ
    J Cell Physiol; 1998 Aug; 176(2):365-73. PubMed ID: 9648924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors.
    He SH; Chen P; Chen HQ
    Acta Pharmacol Sin; 2003 Sep; 24(9):923-9. PubMed ID: 12956943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic studies on the inhibitions of mast cell chymase by natural serine protease inhibitors: indications for potential biological functions of these inhibitors.
    Fukusen N; Kato Y; Kido H; Katunuma N
    Biochem Med Metab Biol; 1987 Oct; 38(2):165-9. PubMed ID: 3479119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor.
    Scarpi D; McBride JD; Leatherbarrow RJ
    Bioorg Med Chem; 2004 Dec; 12(23):6045-52. PubMed ID: 15519150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The classical Bowman-Birk soy inhibitor is an effective inhibitor of human granulocyte alpha-chymotrypsin and cathepsin G].
    Gladysheva IP; Larionova NI; Gladyshev DP; Tikhonova TV; Kazanskaia NF
    Biokhimiia; 1994 Apr; 59(4):513-8. PubMed ID: 8018773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase.
    Goldstein SM; Leong J; Schwartz LB; Cooke D
    J Immunol; 1992 Apr; 148(8):2475-82. PubMed ID: 1560203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
    Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
    J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies and inhibitor of chymase are incorporated into mast cell granules and inhibit histamine release.
    Kido H; Fukusen N; Katunuma N
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():95-100. PubMed ID: 2462436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of human leukocyte elastase with plasma fibronectin and its inhibition by soybean Bowman-Birk protease inhibitor.
    Larionova NI; Balabushevitch NG; Zhatikov PA
    Biochemistry (Mosc); 1998 Sep; 63(9):1078-82. PubMed ID: 9795279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between duodenase, a proteinase with dual specificity, and soybean inhibitors of Bowman-Birk and Kunitz type.
    Gladysheva IP; Zamolodchikova TS; Sokolova EA; Larionova NI
    Biochemistry (Mosc); 1999 Nov; 64(11):1244-9. PubMed ID: 10611528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
    Chen YW; Huang SC; Lin-Shiau SY; Lin JK
    Carcinogenesis; 2005 Jul; 26(7):1296-306. PubMed ID: 15746161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
    Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
    Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
    J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological functions of serine proteases in mast cells in allergic inflammation.
    Katunuma N; Kido H
    J Cell Biochem; 1988 Dec; 38(4):291-301. PubMed ID: 2467915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.
    He S; Gaça MD; McEuen AR; Walls AF
    J Pharmacol Exp Ther; 1999 Nov; 291(2):517-23. PubMed ID: 10525066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin.
    Lohi J; Harvima I; Keski-Oja J
    J Cell Biochem; 1992 Dec; 50(4):337-49. PubMed ID: 1469068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor.
    Billings PC; Habres JM; Liao DC; Tuttle SW
    Cancer Res; 1991 Oct; 51(20):5539-43. PubMed ID: 1913672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport.
    Dittmann K; Mayer C; Kehlbach R; Rodemann HP
    Radiother Oncol; 2008 Mar; 86(3):375-82. PubMed ID: 18237807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.